Faculty Database Production Server | David Geffen School of Medicine at UCLA
Loop | Giuseppe Giaccone
Dr. Giuseppe Giaccone, MD, PhD | New York, NY | Oncologist
Dr. Ashish Saxena, MD – New York, NY | Oncology
Giuseppe VIALE | Professor (Full) | MD, FRCPath | University of Milan, Milan | UNIMI | Department of Oncology and hemato-oncology; European Institute of Oncology | Research profile
Atezolizumab bests chemo in NSCLC patients with high PD-L1 expression | MDedge Hematology and Oncology
Dr. Giaccone on Investigational Agents in Thymic Cancers
Giuseppe Giaccone, PhD, MD, comments on the incidence of HLA-A2 positive (NSCLC) - YouTube
Giuseppe Giaccone, Ph.D., M.D. at Lung Cancer and Thoracic Oncology Program: Hematology/Oncology | NewYork-Presbyterian Doctor in New York, NY
Principles of Molecular Oncology: 9781934115251: Medicine & Health Science Books @ Amazon.com
ITMIG 2017# Interview with Dr. Giuseppe Giaccone: We should focus on data, and keep up-to-date - YouTube
Giuseppe Giaccone, PhD, MD, speculates on next steps in the development of Tedopi (OSE2101) - YouTube
Giuseppe Giaccone, MD PhD, National Cancer Institute on Vimeo
Malcolm V. Brock, MD, Johns Hopkins Sidney Kimmel Comprehensive Cancer Center on Vimeo
Targeted Therapies in Oncology: 9780367379360: Medicine & Health Science Books @ Amazon.com
Dr. Giuseppe Giaccone | Mesothelioma Expert in New York
PPT - Tyrosine Kinase Inhibitors in non-small cell lung cancer PowerPoint Presentation - ID:3372145
Loop | Giuseppe Giaccone
Giuseppe Giaccone, PhD, MD, regarding the step 1 results of the Phase III ATALANTE-1 trial in NSCLC - YouTube
Giuseppe Giaccone: Leading Clinical Oncology Research Expansion | Georgetown University Medical Center | Georgetown University
Dr. Giaccone on Investigational Agents in Thymic Cancers
Dramatic Response to Sequential BRAF Inhibition in BRAF V600E–Mutant Metastatic Lung Adenocarcinoma | JCO Precision Oncology
Dr. Giuseppe Giaccone, MD, PhD | New York, NY | Oncologist
Stephen V Liu, MD on X: "#ESMO20 Beppe Giaccone presents the phase 3 Atalante-1 trial of the vaccine OSE-2101 vs standard chemotherapy (docetaxel or pemetrexed) in patients with #NSCLC after immune checkpoint
Loop | Giuseppe Giaccone
Loop | Giuseppe Giaccone
Targeting the Epigenome in Lung Cancer: Expanding Approaches to Epigenetic Therapy – topic of research paper in Clinical medicine. Download scholarly article PDF and read for free on CyberLeninka open science hub.
